Att A - Offeror Capabilities and Specimens.xlsx

XLSX spreadsheet 27 KB Posted

Attached to
CDC Multistate Assessment of SARS-CoV-2 Seroprevalence (MASS) Study
Solicitation number
75D301-20-R-68127
Issued by

About this file

This document contains a pre-solicitation notice and related proposal questions for a federal contract to conduct laboratory testing of blood specimens. The Centers for Disease Control and Prevention intends to competitively award a fixed price, ten month contract to determine U.S. SARS-CoV-2 seroprevalence by region, age, and time through testing residual blood specimens. Offerors should respond with the number and demographic information of specimens they can test under three task areas over nine months in total. Testing will provide sample results and metadata in both Excel and CSV formats. Proposals are due approximately 20 days after solicitation release on the FedBizOpps website. Award will be made using a best value tradeoff approach prioritizing technical merit and past performance over price, with potential for multiple awards.

View the file

Other files

File Type Posted
Att B - Task Deliverables Table.xlsx XLSX spreadsheet
Draft Performance Work Statement.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Proposal Responses

Each offeror should complete and include the below table and subsequent worksheets with their proposal.
IDQuestionAnswer
A.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a one day period that could be used in this study?
A.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "A.3".
B.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a two week period that could be used in this study?
B.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "B.3".
C.1How many total specimens from each US state (+ DC and Puerto Rico), stratefied by age group, do you typically accumulate over a four week period that could be used in this study?
C.2Provide aggregated, available information on the specimens referenced in Question 1 in the below worksheet tab labeled "B.3".
DWill you provide sample results and metadata information as both Excel and .CSV file types?
EHow many specimens can you test under Task Area 1 every two weeks for 3 months?
FHow many specimens can you test under Task Area 2 every two weeks for 1.5 months?
GHow many specimens can you test under Task Area 3 every two weeks for 1.5 months?

A.3

With reference to Questions A.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

B.3

With reference to Questions B.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

C.3

With reference to Questions C.1 in "Proposal Responses", provide any of the below information readily available:
State/ TerritoryEstimated # of available specimensAge group (0 months to ≤17 years, 18 to ≤49 years, 50 to ≤64 years, and 65+ years)% Male

File details come from the government source that posted it. Updated .